- Home
- FLNT vs ALVR Comparison
FLNT vs ALVR Comparison
Compare FLNT & ALVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLNT
- ALVR
- Stock Information
- Founded
- FLNT 2010
- ALVR 2013
- Country
- FLNT United States
- ALVR United States
- Employees
- FLNT N/A
- ALVR N/A
- Industry
- FLNT Advertising
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLNT Consumer Discretionary
- ALVR Health Care
- Exchange
- FLNT Nasdaq
- ALVR Nasdaq
- Market Cap
- FLNT 47.1M
- ALVR 52.2M
- IPO Year
- FLNT N/A
- ALVR 2020
- Fundamental
- Price
- FLNT $2.91
- ALVR $0.45
- Analyst Decision
- FLNT Hold
- ALVR Sell
- Analyst Count
- FLNT 1
- ALVR 5
- Target Price
- FLNT $4.00
- ALVR $1.00
- AVG Volume (30 Days)
- FLNT 21.8K
- ALVR 340.7K
- Earning Date
- FLNT 11-14-2024
- ALVR 11-12-2024
- Dividend Yield
- FLNT N/A
- ALVR N/A
- EPS Growth
- FLNT N/A
- ALVR N/A
- EPS
- FLNT N/A
- ALVR N/A
- Revenue
- FLNT $261,976,999.00
- ALVR N/A
- Revenue This Year
- FLNT N/A
- ALVR N/A
- Revenue Next Year
- FLNT $6.23
- ALVR N/A
- P/E Ratio
- FLNT N/A
- ALVR N/A
- Revenue Growth
- FLNT N/A
- ALVR N/A
- 52 Week Low
- FLNT $2.31
- ALVR $0.40
- 52 Week High
- FLNT $4.80
- ALVR $2.42
- Technical
- Relative Strength Index (RSI)
- FLNT 49.52
- ALVR 31.87
- Support Level
- FLNT $2.59
- ALVR $0.40
- Resistance Level
- FLNT $2.89
- ALVR $0.53
- Average True Range (ATR)
- FLNT 0.15
- ALVR 0.04
- MACD
- FLNT 0.01
- ALVR 0.00
- Stochastic Oscillator
- FLNT 71.87
- ALVR 27.34
About FLNT Fluent Inc.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers they are seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.